Skip to main content

Altered Platelet Responses to Thromboxane A2 in Patients with Myelo-Proliferative Disorders

  • Conference paper

Abstract

Thromboxane A2 (TXA2), a major arachidonic acid (AA) metabolite in platelets, is a potent stimulator of platelet functions and constrictor of vascular and respiratory smooth muscles [1,2]. Because of such potent biological activities and its formation in response to various stimuli, TXA2 has been implicated as a mediator in many pathophysiological conditions including myocardial infarction, stroke and anaphylaxis [2,3]. Furthermore, platelet dysfunctions due to defective TXA2 synthesis or subnormal responses to TXA2 are associated with bleeding tendency [4].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammerström S, Malmsten C (1978) Ann Rev Biochem 47: 997–1029

    Article  PubMed  CAS  Google Scholar 

  2. Granström E, Diczfalusy U, Hamberg M (1983) Prostaglandins and related substances. Elsevier Science Publishers. Amsterdam, pp 45–94

    Book  Google Scholar 

  3. Ogletree ML (1987) Fed Proc 46: 133–138

    PubMed  CAS  Google Scholar 

  4. Hardisty RM, Caen JP (1987) Haemostasis and thrombosis. Churchill Livingstone. London, pp365–392

    Google Scholar 

  5. Schafer Al (1984) Blood 64: 1–12

    Google Scholar 

  6. Okuma M (1989) Acta Haematol Jpn 52: 1265–1272

    CAS  Google Scholar 

  7. Okuma M, Takayama H, Uchino H (1982) Br J Haematol 51: 469–477

    Article  PubMed  CAS  Google Scholar 

  8. Ushikubi F, Okuma M, Kanaji K, Sugiyama T, Ogorochi T, Narumiya S, Uchino H (1987) Thromb Haemost 57: 158–164

    PubMed  CAS  Google Scholar 

  9. Ushikubi F, Nakajima M, Yamamoto M, Ohts K, Kimura Y, Okuma M, Uchino H, Narumiya S (1989) Eicosanoid 2: 21–27

    CAS  Google Scholar 

  10. Cassel D, Selinger Z (1977) Biochem Biophys Res Commun 77: 868–873

    Article  PubMed  CAS  Google Scholar 

  11. Murray R, FitzGerald GA (1989) Proc Natl Acad Sei USA 86: 124–128

    Article  CAS  Google Scholar 

  12. Cortelazzo S, Galli M, Castagna D, Viero P, de Gaetano G, Barbui T (1988) Thromb Haemost 59: 73–76

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Japan

About this paper

Cite this paper

Okuma, M., Ushikubi, F., Ishibashi, T., Narumiya, S., Tomo, K., Takayama, H. (1992). Altered Platelet Responses to Thromboxane A2 in Patients with Myelo-Proliferative Disorders. In: Takada, A., Budzynski, A.Z. (eds) Hemostasis and Circulation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66925-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-66925-8_17

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-70096-8

  • Online ISBN: 978-4-431-66925-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics